Jump Financial’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-103,826
| Closed | -$1.06M | – | 1968 |
|
2025
Q1 | $1.06M | Buy |
+103,826
| New | +$1.06M | 0.01% | 797 |
|
2024
Q4 | – | Sell |
-15,503
| Closed | -$900K | – | 1837 |
|
2024
Q3 | $900K | Buy |
15,503
+1,822
| +13% | +$106K | 0.02% | 840 |
|
2024
Q2 | $625K | Buy |
+13,681
| New | +$625K | 0.01% | 1036 |
|
2023
Q3 | – | Sell |
-7,283
| Closed | -$293K | – | 2060 |
|
2023
Q2 | $293K | Buy |
+7,283
| New | +$293K | 0.01% | 1319 |
|
2022
Q4 | – | Sell |
-8,344
| Closed | -$314K | – | 1828 |
|
2022
Q3 | $314K | Sell |
8,344
-13,634
| -62% | -$513K | 0.01% | 1123 |
|
2022
Q2 | $607K | Buy |
+21,978
| New | +$607K | 0.03% | 763 |
|